A Win For Hancock Jaffe Laboratories, Inc.
Wed 08 Jan 20 at 05:30 PM
Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ) rocketted at $0.72, a gain of 31.1%. On Tue 07 Jan 20, HJLI:NASDAQ hit a New 2-Week Intraday High of $0.58. The stock got featured on our News Catalysts scanner on Wed 08 Jan 20 at 09:17 AM in the 'RECOMMENDATION' category. From Mon 16 Dec 19, the stock recorded 42.86% Up Days and 60.00% Green Days
About Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ)
Hancock Jaffe Laboratories Inc development stage medical device company. It develops and sells biological tissue solutions to treat patients with coronary, vascular, end stage renal and peripheral arterial diseases in the United States and Europe.
Top 10 Gainers:
- ShiftPixy, Inc. (PIXY:NASDAQ), 148.71%
- Midatech Pharma plc (MTP:NASDAQ), 52.65%
- ToughBuilt Industries, Inc. (TBLT:NASDAQ), 45.72%
- ECMOHO Limited (MOHO:NASDAQ), 41.69%
- Verastem, Inc. (VSTM:NASDAQ), 36.51%
- Applied Therapeutics, Inc. (APLT:NASDAQ), 34.48%
- IsoRay, Inc. (ISR:NYSEMKT), 34.43%
- Wah Fu Education Group Limited (WAFU:NASDAQ), 33.53%
- Summer Infant, Inc. (SUMR:NASDAQ), 31.38%
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 31.09%